{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T17:38:53Z","timestamp":1780421933202,"version":"3.54.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2002,9,1]],"date-time":"2002-09-01T00:00:00Z","timestamp":1030838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,9,1]],"date-time":"2002-09-01T00:00:00Z","timestamp":1030838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":3972,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2002,9]]},"DOI":"10.1053\/seiz.2001.0655","type":"journal-article","created":{"date-parts":[[2003,10,31]],"date-time":"2003-10-31T12:53:05Z","timestamp":1067604785000},"page":"406-410","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"title":["Topiramate monotherapy for childhood absence seizures: an open label pilot study"],"prefix":"10.1053","volume":"11","author":[{"given":"J.Helen","family":"Cross","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/seiz.2001.0655_RF1","series-title":"Pediatric Epilepsy: Diagnosis and Therapy","first-page":"157","article-title":"Absence seizures","author":"Pearl","year":"1993"},{"key":"10.1053\/seiz.2001.0655_RF2","series-title":"The Treatment of Epilepsy: Principles and Practice","first-page":"547","article-title":"Childhood absence epilepsy and juvenile absence epilepsy","author":"Berkovic","year":"1993"},{"key":"10.1053\/seiz.2001.0655_RF3","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1001\/archneur.1996.00550090141020","article-title":"Accidental injury is a serious risk in children with typical absence epilepsy","volume":"53","author":"Wirrell","year":"1996","journal-title":"Archives of Neurology"},{"key":"10.1053\/seiz.2001.0655_RF4","first-page":"S11","article-title":"Standard approach to antiepileptic drug treatment in the United States","volume":"35 (Suppl. 4)","author":"Pellock","year":"1994","journal-title":"Epilepsia"},{"key":"10.1053\/seiz.2001.0655_RF5","series-title":"Pediatric Epilepsy: Diagnosis and Therapy","first-page":"253","article-title":"Adverse effects of antiepileptic drugs","author":"Pellock","year":"1993"},{"key":"10.1053\/seiz.2001.0655_RF6","series-title":"Adverse Effects of Antiepileptic Drugs","author":"Schmidt","year":"1982"},{"key":"10.1053\/seiz.2001.0655_RF7","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/j.1528-1157.2000.tb00258.x","article-title":"Refractory idiopathic absence status epilepticus: a probable paradoxical effect of phenytoin and carbamazepine","volume":"41","author":"Osorio","year":"2000","journal-title":"Epilepsia"},{"key":"10.1053\/seiz.2001.0655_RF8","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/0887-8994(86)90074-3","article-title":"Carbamazepine-exacerbated epilepsy in children and adolescents","volume":"2","author":"Horn","year":"1986","journal-title":"Pediatric Neurology"},{"key":"10.1053\/seiz.2001.0655_RF9","first-page":"513","article-title":"Newer antiepileptic drugs: gabapentin, lamotrigine, felbamate, topiramate and fosphenytoin","volume":"57","author":"Curry","year":"1998","journal-title":"American Family Physician"},{"key":"10.1053\/seiz.2001.0655_RF10","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/j.1528-1157.1999.tb00805.x","article-title":"Lamictal (lamotrigine) monotherapy for typical absence seizures in children","volume":"40","author":"Frank","year":"1999","journal-title":"Epilepsia"},{"key":"10.1053\/seiz.2001.0655_RF11","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1111\/j.1528-1157.2000.tb02178.x","article-title":"Effectiveness, tolerability, and safety of topiramate in children with partial-onset seizures. Topiramate YP study group","volume":"41 (Suppl. 1)","author":"Ritter","year":"2000","journal-title":"Epilepsia"},{"key":"10.1053\/seiz.2001.0655_RF12","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1111\/j.1528-1157.2000.tb02175.x","article-title":"Topiramate as add-on therapy: pooled analysis of randomized controlled trials","volume":"41 (Suppl. 1)","author":"Reife","year":"2000","journal-title":"Epilepsia"},{"key":"10.1053\/seiz.2001.0655_RF13","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1111\/j.1528-1157.2000.tb02177.x","article-title":"Nonfocal generalized tonic\u2013clonic seizures: response during long-term topiramate treatment. Topiramate YTC\/YTCE study group","volume":"41 (Suppl. 1)","author":"Montouris","year":"2000","journal-title":"Epilepsia"},{"key":"10.1053\/seiz.2001.0655_RF14","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1017\/S0317167100034843","article-title":"Topiramate use in pediatric patients","volume":"25","author":"Glauser","year":"1998","journal-title":"Canadian Journal of Neurological Sciences"},{"key":"10.1053\/seiz.2001.0655_RF15","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1212\/WNL.52.9.1882","article-title":"A double-blind, randomized trial of topiramate in Lennox\u2013Gastaut syndrome","volume":"52","author":"Sachdeo","year":"1999","journal-title":"Neurology"},{"key":"10.1053\/seiz.2001.0655_RF16","first-page":"S71","article-title":"Topiramate","volume":"40 (Suppl. 5)","author":"Glauser","year":"1999","journal-title":"Epilepsia"},{"key":"10.1053\/seiz.2001.0655_RF17","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1651-2227.1985.tb10994.x","article-title":"Evaluation of treatment in typical absence seizures. The roles of long-term EEG monitoring and ethosuximide","volume":"74","author":"Blomquist","year":"1985","journal-title":"Acta Paediatrica Scandinavica"},{"key":"10.1053\/seiz.2001.0655_RF18","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/archneur.1983.04210070009004","article-title":"Clinical and EEG estimates of absence seizure frequency","volume":"40","author":"Browne","year":"1983","journal-title":"Archives of Neurology"},{"key":"10.1053\/seiz.2001.0655_RF19","series-title":"Epileptic Syndromes in Infancy, Childhood and Adolescence","first-page":"135","article-title":"Childhood absence epilepsy","author":"Loiseau","year":"1992"},{"key":"10.1053\/seiz.2001.0655_RF20","series-title":"Treatment of Epilepsy","first-page":"471","article-title":"Topiramate: a novel antiepileptic agent","author":"Reife","year":"1996"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131101906557?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131101906557?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:28:08Z","timestamp":1761010088000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131101906557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,9]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2002,9]]}},"alternative-id":["S1059131101906557"],"URL":"https:\/\/doi.org\/10.1053\/seiz.2001.0655","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2002,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topiramate monotherapy for childhood absence seizures: an open label pilot study","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/seiz.2001.0655","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2002 BEA Trading, Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}